First identification of an Escherichia coli clinical isolate producing both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1

被引：40

作者：

Galani, I ^{[1
]}

Souli, M ^{[1
]}

Chryssouli, Z ^{[1
]}

Katsala, D ^{[1
]}

Giamarellou, H ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Dept Internal Med 4, Mol Biol Sect, GR-11527 Athens, Greece

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期

关键词：

bla(IBC-1); bla(VIM-2); carbapenemase; Escherichia coli; metallo-beta-lactamase; resistance;

D O I：

10.1111/j.1469-0691.2004.00913.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

An Escherichia coli strain with decreased susceptibility to carbapenems was isolated from a hospitalised patient in Athens, Greece. The strain was resistant to all beta-lactarns, including aztreonam, whereas the MIC of imipenem and meropenem was 0.5 mg/L. A positive EDTA-disk synergy test suggested the production of a metallo-beta-lactamase. PCR experiments revealed the presence of the bla(VIM-2), bla(IBC-1) and bla(TEM-1) genes. Resistance to beta-lactams was not transferable by conjugation. This is the first report of a clinical isolate of E. coli producing VIM-2, and the first report of the coexistence of bla(VIM-2) and bla(IBC-1) in a single clinical isolate.

引用

页码：757 / 760

页数：4

共 19 条

[1] Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40
[2] IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain
Giakkoupi, P
Tzouvelekis, LS
Tsakris, A
Loukova, V
Sofianou, D
Tzelepi, E
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2247 - 2253
[3] Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals
Giakkoupi, P
Petrikkos, G
Tzouvelekis, LS
Tsonas, S
Legakis, NJ
Vatopoulos, AC
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) : 822 - 825
[4] VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals
Giakkoupi, P
Xanthaki, A
Kanelopoulou, M
Vlahaki, A
Miriagou, V
Kontou, S
Papafraggas, E
Malamou-Lada, H
Tzouvelekis, LS
Legakis, NJ
Vatopoulos, AC
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3893 - 3896
[5] Outbreak of infections caused by Enterobacter cloacae producing the integron-associated β-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital
Kartali, G
Tzelepi, E
Pournaras, S
Kontopoulou, C
Kontos, F
Sofianou, D
Maniatis, AN
Tsakris, A
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1577 - 1580
[6] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
Lauretti, L
Riccio, ML
Mazzariol, A
Cornaglia, G
Amicosante, G
Fontana, R
Rossolini, GM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1584 - 1590
[7] blaVIM-2 Cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital
Lee, K
Lim, JB
Yum, JH
Yong, DG
Chong, YS
Kim, JM
Livermore, DM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1053 - 1058
[8] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece
Mavroidi, A
Tsakris, A
Tzelepi, E
Pournaras, S
Loukova, V
Tzouvelekis, LS
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1041 - 1043
[9] Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1
Miriagou, V
Tzelepi, E
Gianneli, D
Tzouvelekis, LS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 395 - 397
[10] National Committee for Clinical Laboratory Standards, 2004, M100S14 NCCLS

← 1 2 →